KWM
Koa Wealth Management Portfolio holdings
AUM
$146M
1-Year Est. Return
21.12%
This Fund
S&P 500
1 Year Est. Return
+21.12%
AUM
$135M
AUM Growth
+$8.93M
(+7.1%)
Holding
59
Top Buys
| 1 | +$1.33M | |
| 2 | +$911K | |
| 3 | +$905K | |
| 4 |
Copart
CPRT
|
+$900K |
| 5 |
American Tower
AMT
|
+$809K |
Top Sells
| 1 | +$3.77M | |
| 2 | +$2.23M | |
| 3 | +$1.84M | |
| 4 |
Alphabet (Google) Class A
GOOGL
|
+$850K |
| 5 |
State Street Utilities Select Sector SPDR ETF
XLU
|
+$436K |
Sector Composition
| 1 | Financials | 23.6% |
| 2 | Technology | 15.47% |
| 3 | Healthcare | 10.93% |
| 4 | Consumer Discretionary | 7.45% |
| 5 | Consumer Staples | 6.56% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
51
JPMorgan Equity Premium Income ETF
JEPI
$42.9B
| $241K | 0.18% |
4,218
-333
|
|
||
52
DexCom
DXCM
$28.9B
| $224K | 0.17% |
3,325
|
|
||
53
Avidity Biosciences
RNA
$10.9B
| $218K | 0.16% |
+5,000
|
|
||
54
Vanguard S&P 500 ETF
VOO
$854B
| $202K | 0.15% |
+329
|
|
||
55
Pacific Biosciences
PACB
$716M
| $154K | 0.11% |
120,000
|
|
||
56
Perspective Therapeutics
CATX
$317M
| $89.1K | 0.07% |
25,975
|
|
||
|
CNTB
57
Connect Biopharma Holdings
CNTB
$143M
| $74.9K | 0.06% |
49,600
|
|
||
58
Innovative Industrial Properties
IIPR
$1.36B
| – | – |
-68,221
|
|
||
59
AstraZeneca
AZN
$287B
| – | – |
-26,260
|
|